B
BioLine RX Ltd
TASE:BLRX
BioLine RX Ltd
TASE:BLRX
Price:
17 ILS
-1.73%
Market Closed
Updated:
Jun 10, 2024
BioLine RX Ltd
EPS (Diluted)
|
BioLine RX Ltd
EPS (Diluted) Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
EPS (Diluted)
$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
EPS (Diluted)
$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
EPS (Diluted)
-$3
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
EPS (Diluted)
$0
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
EPS (Diluted)
₪0
|
CAGR 3-Years
-96%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
-10%
|
See Also
What is BioLine RX Ltd's EPS (Diluted)?
EPS (Diluted)
-0.1
USD
-0.1
USD
Based on the financial report for Dec 31, 2023, BioLine RX Ltd's EPS (Diluted) amounts to -0.1 USD.
What is BioLine RX Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
21%
21%
Over the last year, the EPS (Diluted) growth was -100%. The average annual EPS (Diluted) growth rates for BioLine RX Ltd have been 21% over the past three years , 22% over the past five years , and 21% over the past ten years .
You don't have any saved screeners yet
